Page results
-
UCLH vision, values and strategy
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Advice on socialising and managing friendships for young people living with fatigue conditions.
File results
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0333 - Elective treatment wait over 65 weeks
-
FOI/2024/0337 - IVF clinical unit/ embryology laboratory
-
FOI/2024/0338 - Ophthalmology outpatient activity 2022, 2023 and 2024
-
FOI/2024/0339 - PACS, VNA, RIS, digital pathology and cardiology PACS systems
-
FOI/2024/0341 - Robotic Process Automation (RPA)/ Intelligent Automation (IA) technology at Trust
-
FOI/2024/0344 - Cancer diagnosis following A&E attendance 2018-2023
-
FOI/2024/0347 - Paediatric elective surgical waiting lists
-
FOI/2024/0349 - Trust's operations and tele reporting services/ outsourced and insourced
-
FOI/2024/0354 - Staff details for estates and facilities